Patent Assignment
Reel/Frame 049924/0466
Change of Name
Recorded: 2019-07-31
Pages: 8
Assignor
AERPIO THERAPEUTICS, INC.
Executed: 2017-03-15
Assignee
AERPIO THERAPEUTICS LLC
9987 CARVER ROAD, CINCINNATI, OHIO, 45242
Covered Properties
(4)
Compositions and Methods for Treating Ocular Edema, Neovascularization and Related Diseases
Application:
13/253,397 →
Publication:
US 2012/0129847
Compositions and Methods for Treating Ocular Edema, Neovascularization and Related Diseases
Application:
15/462,326 →
Publication:
US 2018/0037579
Phosphatase Inhibitors for Treating Ocular Diseases
Application:
15/796,293 →
Publication:
US 2018/0092883
Compositions and Methods for Treating Ocular Edema and Neovascularization and Related Diseases
Application:
61/390,899 →
Related Assignments
(4)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Apr 5, 2017
From: PETERS, KEVIN GENE; SHALWITZ, ROBERT
To: AERPIO THERAPEUTICS, INC.
Reel/Frame 041853/0034 →
Assignment of Assignor's Interest
Dec 4, 2017
From: PETERS, KEVIN GENE; SHALWITZ, ROBERT
To: AERPIO THERAPEUTICS, INC.
Reel/Frame 044287/0185 →
Assignment of Assignor's Interest
Apr 17, 2020
From: AERPIO THERAPEUTICS LLC
To: AERPIO PHARMACEUTICALS, INC.
Reel/Frame 052432/0789 →
Assignment of Assignor's Interest
Sep 9, 2021
From: AERPIO PHARMACEUTICALS, INC.
To: EYEPOINT PHARMACEUTICALS, INC.
Reel/Frame 057448/0033 →